The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women
Open accessAbstract
Women with polycystic ovary syndrome (PCOS) are insulin resistant, have insulin secretory defects, and are at high risk for glucose intolerance. We performed this study to determine the prevalence of glucose intolerance and parameters associated with risk for this in PCOS women. Two-hundred and fifty-four PCOS women, aged 14-44 yr, were prospectively evaluated at 2 centers, 1 urban and ethnically diverse (n = 110) and 1 rural and ethnically homogeneous (n = 144). The rural PCOS women were compared to 80 control women of similar weight, ethnicity, and age. A 75-g oral glucose challenge was administered after a 3-day 300-g carbohydrate diet and an overnight fast with 0 and 2 h blood samples for glucose levels. Diabetes was categorized according to WHO criteria. The prevalence of glucose intolerance was 31.1% impaired glucose intolerance (IGT) and 7.5% diabetes. In nonobese PCOS women (body mass index, <27 kg/m2), 10.3% IGT and 1.5% diabetes were found. The prevalence of glucose intolerance was significantly higher in PCOS vs. control women (chi2 = 7.0; P = 0.01; odds ratio = 2.76; 95% confidence interval = 1.23-6.57). Variables most associated with postchallenge glucose levels were fasting glucose levels (P < 0.0001), PCOS status (P = 0.002), waist/hip ratio (P = 0.01), and body mass index (P = 0.021). The American Diabetes Association criteria applied to fasting glucose significantly underdiagnosed diabetes compared to the WHO criteria (3.2% vs. 7.5%; chi2 = 4.7; P = 0.046; odds ratio = 2.48; 95% confidence interval = 1.01-6.69). We conclude that 1) PCOS women are at significantly increased risk for IGT and type 2 diabetes mellitus at all weights and at a young age; 2) these prevalence rates are similar in 2 different populations of PCOS women, suggesting that PCOS may be a more important risk factor than ethnicity or race for glucose intolerance in young women; and 3) the American Diabetes Association diabetes diagnostic criteria failed to detect a significant number of PCOS women with diabetes by postchallenge glucose values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As such, women with PCOS exhibit increased risk of impaired glucose tolerance and T2DM regardless of weight and age [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“Approximately 50–70% of women with PCOS have IR and hyperinsulinaemia [128], whereas many also present evidence of glucose intolerance [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“In women with PCOS, dysglycemia typically consists of impaired glucose tolerance [12], its prevalence being of almost 30% in both adult women [13] and affected adolescents [14].”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [12]
In the citing paper
“PCOS patients commonly have metabolic complications, such as type 2 diabetes, insulin resistance (IR), and adipose tissue dysfunction (7–9).”
From Circulating Adipokine Levels in Nonobese Women with Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis (2021) · cites this paper as [7]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“In PCOS, other novel CVD risk factors, premature cardiovascular dysfunction and subclinical CVD 29,30,83 have been noted and are related to IR and obesity. 84-89”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [85]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 901–1,000 of 1,388
da Silva, R. C. Q., Miranda, W. L., Chacra, A. R., & Dib, S. A. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.11.006 · Cited by 21
Polycystic ovarian syndrome in adolescents
Creatsas, G. K., & Deligeoroglou, E. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3282efdc54 · Cited by 21
Göde, F., Karagöz, Ç., Posacı, C., Saatli, B., Uysal, D., Seçil, M., & Akdeniz, B. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-010-1790-9 · Cited by 21
Taylor, M. C., Kar, A. R., Kunselman, A. R., Stetter, C., Dunaif, A. E., & Legro, R. S. (2011) · Human Reproduction · doi:10.1093/humrep/der101 · Cited by 21
Self-citationJensterle, M., Janež, A., Vrtovec, B., Meden‐Vrtovec, H., Pfeifer, M., Preželj, J., & Kocjan, T. (2007) · Croatian Medical Journal · doi:10.3325/cmj.2007.6.864 · Cited by 21
Polycystic ovary syndrome in adolescent girls
Pfeifer, S. M. (2005) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2005.01.007 · Cited by 21
Glucose Metabolism in Overweight Hispanic Adolescents With and Without Polycystic Ovary Syndrome
Nur, M. M., Newman, I. M., & Siqueira, L. (2009) · Pediatrics · doi:10.1542/peds.2008-2050 · Cited by 21
Diabetes prevalence and risk factors in polycystic ovary syndrome
Legro, R. S. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200212000-00003 · Cited by 20
Self-citationBiernacka-Bartnik, A., Kocełak, P., Owczarek, A. J., Choręza, P. S., Puzianowska‐Kuźnicka, M., Markuszewski, L., Madej, P., Chudek, J. T., & Olszanecka‐Glinianowicz, M. (2022) · International Journal of Endocrinology · doi:10.1155/2022/6498768 · Cited by 24
Ovulation induction techniques in women with polycystic ovary syndrome
Vyrides, A., Mahdi, E. E., & Giannakou, K. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.982230 · Cited by 27
Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
Choudhari, R. G., Tayade, S. A., Tiwari, A., & Satone, P. D. (2024) · Cureus · doi:10.7759/cureus.58733 · Cited by 29
Yapça, Ö. E., Turan, M. İ., Börekçi, B., Akçay, F., & Süleyman, H. (2014) · PubMed Central · Cited by 21
Espinós, J. J., Corcoy, R., & Calaf, J. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802585597 · Cited by 21
Maliqueo, M. A. (2003) · Human Reproduction · doi:10.1093/humrep/deg482 · Cited by 21
Morris, S., Grover, S. R., & Sabin, M. A. (2015) · Clinical Obesity · doi:10.1111/cob.12123 · Cited by 20
Relationship of subclinical hypothyroidism and obesity in polycystic ovarian syndrome patients
Nayak, P., Mitra, S., Sahoo, J., Mahapatra, E., Agrawal, S., & Lone, Z. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_654_19 · Cited by 20
Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome
Livadas, S., Paparodis, R. D., Anagnostis, P. G., Gambineri, A., Μacut, D., Petrović, T., Yıldız, B. O., Micić, D., Mastorakos, G. P., & Μacut, D. (2023) · Diagnostics · doi:10.3390/diagnostics13122067 · Cited by 23
Leblanc, S., Battista, M., Noll, C., Hallberg, A., Gallo‐Payet, N., Carpentier, A. C., Vine, D. F., & Baillargeon, J. (2014) · Endocrinology · doi:10.1210/en.2014-1185 · Cited by 19
Current trends in the treatment of polycystic ovary syndrome with desire for children
Checa, M. Á. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3779 · Cited by 20
Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome
Mumm, H., Altinok, M. L., Henriksen, J. E., Ravn, P., Glintborg, D., & Andersen, M. (2016) · Human Reproduction · doi:10.1093/humrep/dew046 · Cited by 20
Dikmen, A., Ergenoğlu, A. M., Yeniel, A. Ö., Yılmaz, Ö., Ercan, G., & Yılmaz, H. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.09.042 · Cited by 20
Metabolic Disturbance in PCOS: Clinical and Molecular Effects on Skeletal Muscle Tissue
Dantas, W. S., Gualano, B., Rocha, M. P., Barcellos, C. R. G., Yance, V. D. R. V., & Marcondes, J. A. M. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/178364 · Cited by 22
Sharma, M., Kriplani, A., & Agarwal, N. (2006) · Journal of Gynecologic Surgery · doi:10.1089/gyn.2006.22.105 · Cited by 20
Brown, M. A., & Chang, R. J. (2007) · Ultrasound Quarterly · doi:10.1097/ruq.0b013e318159927f · Cited by 20
Prevention of type 2 diabetes mellitus in polycystic ovary syndrome: A review
Anwar, S., & Shikalgar, N. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.07.015 · Cited by 19
Zweig, S. B., Tolentino, M. C., & Poretsky, L. (2004) · Springer eBooks · doi:10.1007/978-1-4757-6260-0_38 · Cited by 19
Panidis, D., Μacut, D., Farmakiotis, D., Rousso, D., Kourtis, A., Katsikis, I., Spanos, N., Petakov, M. S., Bjekić, J., & Damjanovic, S. S. (2006) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.12.016 · Cited by 20
Prevention of type 2 diabetes in youth: Etiology, promising interventions and recommendations
Ritchie, L. D., Ganapathy, S., Woodward-Lopez, G. M., Gerstein, D. E., & Fleming, S. E. (2003) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2003.00030.x · Cited by 20
Seow, K., Juan, C., Ho, L., Hsu, Y.-P., Lin, Y., Huang, L., & Hwang, J. (2007) · Human Reproduction · doi:10.1093/humrep/del489 · Cited by 20
Yang, R. J., Gao, C., Yan, Y., Huang, Y., Wang, J., Zhang, C., Ma, X., Li, N., Du, X., Zhang, L., et al. (2021) · Sleep And Breathing · doi:10.1007/s11325-021-02376-2 · Cited by 20
Global trends in polycystic ovary syndrome research: A 10-year bibliometric analysis
Shi, N., & Ma, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1027945 · Cited by 20
Bone mineral density and vitamin D in PCOS and hirsutism
Glintborg, D., Hermann, A. P., & Andersen, M. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2013.827384 · Cited by 20
[High frequency of thyroid abnormalities in polycystic ovary syndrome].
Calvar, C. E., Bengolea, S. V., Deutsch, S., Hermes, R., Ramos, G., & Loyato, M. (2015) · PubMed · Cited by 20
Metabolic profile of women with PCOS in Brazil: a systematic review and meta-analysis
Spritzer, P. M., Ramos, R. B., Marchesan, L. B., de Oliveira, M., & Carmina, E. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00636-5 · Cited by 20
de Boer, J. A. M. (2004) · Human Reproduction · doi:10.1093/humrep/deh122 · Cited by 20
Anand, S., Kumar, A., Prasad, A., & Trivedi, K. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15233 · Cited by 21
Bhattacharya, S. M., Jha, A., & DasMukhopadhyay, L. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2015.06.065 · Cited by 19
Lei, H.-L., Wei, H., Chen, P., Hsi, H., & Chien, L. (2015) · Chemosphere · doi:10.1016/j.chemosphere.2015.05.006 · Cited by 19
Insulin resistance influences central opioid activity in polycystic ovary syndrome
Berent‐Spillson, A., Love, T., Pop‐Busui, R., Sowers, M. R., Persad, C. C., Pennington, K. P., Eyvazzadeh, A. D., Padmanabhan, V., Zubieta, J., & Smith, Y. R. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.03.031 · Cited by 19
Insulin resistance in polycystic ovary syndrome: hyperandrogenemia versus normoandrogenemia
Yıldız, B. O., & Gedik, O. (2001) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(01)00458-4 · Cited by 18
Skeletal Muscle Immunometabolism in Women With Polycystic Ovary Syndrome: A Meta-Analysis
Manti, M., Stener‐Victorin, E., & Benrick, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.573505 · Cited by 18
Anjum, S., Askari, S., Riaz, M., & Basit, A. (2020) · Cureus · doi:10.7759/cureus.11860 · Cited by 19
Karabulut, A., Turgut, S., & Turgut, G. (2010) · Gynecological Endocrinology · doi:10.3109/09513591003632167 · Cited by 19
Evaluation of Oxidative Stress and hsCRP in Polycystic Ovarian Syndrome in a Tertiary Care Hospital
Sumithra, N., Lakshmi, R., Menon, N. L., Subhakumari, K. N., & Sheejamol, V. S. (2014) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0427-3 · Cited by 19
Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes
Ortiz-Flores, A. E., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1528231 · Cited by 20
Muneyyirci‐Delale, O., Kaplan, J., Joulak, I., Yang, L., von Gizycki, H., & Nacharaju, V. L. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.769515 · Cited by 19
Menstrual dysfunction in rural young women and the presence of polycystic ovarian syndrome
Chhabra, S. A., & Venkatraman, S. (2010) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443610903294154 · Cited by 19
Oh, Y. S., Lee, T. S., Cheon, G. J., Jang, I., Jun, H., & Park, S. C. (2010) · Molecular Medicine · doi:10.2119/molmed.2009.00105 · Cited by 19
Insulin resistance and polycystic ovary syndrome
Ehrmann, D. A. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0061-y · Cited by 19
Romaguera, J., Morán, C., Diaz-Montes, T. P., Hines, G. A., Cruz, R. I., & Azziz, R. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00566-5 · Cited by 19
Moran, L., Meyer, C., Hutchison, S. K., Zoungas, S., & Teede, H. J. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345790 · Cited by 19
Perelman, D., Coghlan, N., Lamendola, C., Carter, S., Abbasi, F., & McLaughlin, T. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1259407 · Cited by 18
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.1.37 · Cited by 19
Polycystic Ovary Syndrome Susceptibility Loci Inform Disease Etiological Heterogeneity
Zhang, Y., Movva, V. C., Williams, M. S., & Lee, M. T. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122688 · Cited by 20
Interventions for the metabolic dysfunction in polycystic ovary syndrome
Bozdag, G., & Yildiz, B. O. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.008 · Cited by 18
Dasgupta, A., Khan, A., Banerjee, U., Ghosh, M., Pal, M., Chowdhury, K. M., & Dasgupta, S. (2012) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0253-4 · Cited by 18
Parent-of-Origin Effects on Glucose Homeostasis in Polycystic Ovary Syndrome
Kobaly, K. N., Vellanki, P., Sisk, R. K., Armstrong, L. L., Lee, J. Y., Lee, J. J., Hayes, M. G., Urbanek, M., Legro, R. S., & Dunaif, A. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4338 · Cited by 18
Self-citationPolycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?
Khadilkar, S. S. (2016) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-016-0851-9 · Cited by 18
Juan, C., Chen, K.-H., Chen, C.-W., Ho, C.-H., Wang, P., Chen, H.-S., Hwang, J., Lin, Y., & Seow, K. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.05.093 · Cited by 20
Diagnosis and Treatment of Polycystic Ovarian Syndrome and Insulin Resistance
Fleischman, A., & Mansfield, J. (2005) · Pediatric Annals · doi:10.3928/0090-4481-20050901-13 · Cited by 17
Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome
Gateva, A., & Kamenov, Z. A. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.05.037 · Cited by 18
Goodarzi, M. O., Antoine, H. J., Pall, M., Cui, J., Guo, X., & Azziz, R. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.041 · Cited by 18
Park, H. R., Choi, Y., Lee, H., Oh, J. Y., Hong, Y. S., & Sung, Y. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.063 · Cited by 18
The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS
Li, X., Yang, D., Pan, P., Azziz, R., Yang, D., Cheng, Y., & Zhao, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873726 · Cited by 18
Chudzicka-Strugała, I., Kubiak, A., Banaszewska, B., Wysocka, E., Zwoździak, B., Siakowska, M., Pawelczyk, L. A., & Dulęba, A. J. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07833-3 · Cited by 22
Kaur, R., Kaur, T., Sudhir, N., & Kaur, A. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00676-2 · Cited by 19
Brinca, A. T., Anjos, O., Alves, M. M. C., Sousa, Â., Oliani, A. H., Breitenfeld, L., Passarinha, L. A., Ramalhinho, A. C., & Gallardo, E. (2022) · Biomedicines · doi:10.3390/biomedicines10112852 · Cited by 18
de Medeiros, S. F., de Medeiros, M. A. S., Barbosa, B. B., Yamamoto, M. M. W., & Maciel, G. A. R. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05867-x · Cited by 18
Metformin therapy in girls with polycystic ovary syndrome: a self-controlled clinical trial.
Tahereh, N., Bayat, R., & Hamedi, M. (2007) · PubMed · Cited by 18
Joffe, H., Hall, J. E., Cohen, L. S., Taylor, A. E., & Baldessarini, R. J. (2003) · Harvard Review of Psychiatry · doi:10.1080/10673220303957 · Cited by 18
Insulin-sensitisers in the treatment of polycystic ovary syndrome
Teede, H. J., Meyer, C., & Norman, R. J. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.14.2419 · Cited by 18
Metformin in the Treatment of Polycystic Ovary Syndrome
Ab, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785294609 · Cited by 18
Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome
Elkind-Hirsch, K. E. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605030-00005 · Cited by 18
Moran, L. J., Noakes, M., Clifton, P. M., & Norman, R. J. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.02.057 · Cited by 17
Jethaliya, H., Gajjar, N., Patel, V., Deshpande, S., & Patel, R. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00933-y · Cited by 17
Diagnosing Dysglycemia in Adolescents With Polycystic Ovary Syndrome
Gooding, H. C., Milliren, C., St. Paul, M., Mansfield, M. J., & DiVasta, A. (2014) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2013.12.020 · Cited by 17
Akpang, N., Kwiatkowski, J., Zaborowska, Ł., & Ludwin, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094121 · Cited by 16
Diagnóstico del Síndrome de Ovario Poliquístico: nuevos fenotipos, nuevas incógnitas
Merino, P. M., Carolina Schulin-Zeuthen, P., & Ethel Codner, D. (2009) · Revista médica de Chile · doi:10.4067/s0034-98872009000800012 · Cited by 17
Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals
Becerra-Fernández, A., López, G. P., Román, M. M., Martin-Lazaro, J. F., Pérez, M. J. L., Araque, N. A., Rodríguez-Molina, J. M., Sertucha, M. C. B., & Vilas, M. V. A. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.06.012 · Cited by 17
Diagnosis and Treatment of Polycystic Ovary Syndrome in Adolescent Females
Ebersole, A. M., & Bonny, A. E. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000538 · Cited by 17
Iwata, M. C., Porquere, L., Sorpreso, I. C. E., Baracat, E. C., & Soares, J. M. (2015) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.61.03.215 · Cited by 19
Association of the T45G and G276T polymorphisms in the adiponectin gene with PCOS: A meta-analysis
Gao, L., Zhang, Y., Cui, Y., Jiang, Y., Wang, X., & Liu, J. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2010.508543 · Cited by 17
Metabolic disorders in patients with recent gestational diabetes mellitus
Eroglu, D. U., & Zeyneloğlu, H. B. (2006) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2006.00418.x · Cited by 17
A Review on Glycosylated Hemoglobin in Polycystic Ovary Syndrome
Rezaee, M., Asadi, N., Pouralborz, Y., Ghodrat, M., & Habibi, S. (2016) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2016.07.001 · Cited by 19
Weight Change and Antiepileptic Drugs
Biton, V. (2006) · The Neurologist · doi:10.1097/01.nrl.0000202599.21758.9a · Cited by 17
Genetic analysis of candidate genes for the polycystic ovary syndrome
Urbanek, M., & Spielman, R. S. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200212000-00009 · Cited by 17
Gene Targeting in Neuroendocrinology
Candlish, M., Angelis, R. D., Götz, V., & Boehm, U. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140079 · Cited by 20
Chronic anovulation and the polycystic ovary syndrome
KASE, N. G. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.012 · Cited by 16
Effects of polycystic ovary syndrome on health-related quality of life
Upadhya, K. K., & Trent, M. (2007) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.7.6.597 · Cited by 17
Gülbay, G., Yeşilada, E., Çelik, Ö., & Yoloğlu, S. (2017) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2017.18.5.1219 · Cited by 17
Management of anovulatory infertility
Crosignani, P. G., Bianchedi, D., Riccaboni, A., & Vegetti, W. (1999) · Human Reproduction · doi:10.1093/humrep/14.suppl_1.108 · Cited by 17
Heinonen, S. T., Korhonen, S., Helisalmi, S., Koivunen, R. M., Tapanainen, J. S., & Laakso, M. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.031 · Cited by 17
Clinical features, investigations and management of adolescents with polycystic ovary syndrome
Orsino, A., Eyk, N. V., & Hamilton, J. K. (2005) · Paediatrics & Child Health · doi:10.1093/pch/10.10.602 · Cited by 16
Raissouni, N., Kolesnikov, A., Purushothaman, R., SINHA, S. K., Bhandari, S., Bhangoo, A., Malik, S., Mathew, R. P., Baillargeon, J., Hernández, M. I., et al. (2012) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2012-14 · Cited by 16
Korsoff, P., Bogl, L. H., Korhonen, P. E., Kangas, A. J., Soininen, P., Ala‐Korpela, M., Rose, R. J., Kaaja, R., & Kaprio, J. A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00028 · Cited by 16
Galavi, H., Noorzehi, N., Saravani, R., Sargazi, S., Mollashahee‐Kohkan, F., & Shahraki, H. (2018) · Gene Reports · doi:10.1016/j.genrep.2018.06.019 · Cited by 16
Evaluation of insulin sensitivity status in polycystic ovarian syndrome
Wilma Delphine Silvia, C. R., Kavya, N., & Sweta, K. (2011) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(11)60017-0 · Cited by 16
Association of metabolic syndrome in polycystic ovarian syndrome: an observational study
Dey, R., Mukherjee, S., Roybiswas, R., Mukhopadhyay, A., & Biswas, S. C. (2011) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-011-0020-0 · Cited by 16
How Metformin Acts in PCOS Pregnant Women
Romualdi, D., Cicco, S. D., Gagliano, D., Busacca, M., Campagna, G., Lanzone, A., & Guido, M. (2013) · Diabetes Care · doi:10.2337/dc12-2071 · Cited by 16
Pfeifer, S. M. (2003) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/s1083-3188(03)00131-1 · Cited by 16
Metadata
- Authors
- Legro, R. S.
- Affiliations
- Pennsylvania State University (US)
- ORCID
- Legro, R. S.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-01-01
- Volume
- 84
- Issue
- 1
- Pages
- 165-169
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2096126402
- Cited by
- 1,743
- References
- 0
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 36 · 2023: 24 · 2022: 50 · 2021: 64 · 2020: 54 · 2019: 42 · 2018: 43 · 2017: 66 · 2016: 59 · 2015: 88 · 2014: 81 · 2013: 73 · 2012: 84
- FWCI
- 44.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K08 HD-O118, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, type 2 diabetes, impaired glucose tolerance, insulin resistance, insulin secretion, diabetes risk factors, prevalence, fasting blood glucose, waist-to-hip ratio, body mass index, ethnic differences, diagnostic criteria, underdiagnosis, oral glucose tolerance test, young women, obesity
- MeSH terms
- Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Prospective Studies, Risk, Body Mass Index, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
